Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Breast Neoplasms 106Carcinoma, Intraductal, Noninfiltrating 6Neoplasms 4Neoplasm Metastasis 3Breast Neoplasms, Male 3Breast Diseases 3Breast Carcinoma In Situ 3Triple Negative Breast Neoplasms 2Ovarian Neoplasms 2Endometrial Neoplasms 2Breast Cancer Metastatic 2Sexual Dysfunction, Physiological 1Seizures 1Multiple Endocrine Neoplasia Type 1 1Locoregional Recurrence 1Lethal Congenital Contracture Syndrome 2 1Inflammatory Breast Neoplasms 1Hypogonadism 1Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1HER2-positive Breast Cancer 1HER2 Negative Breast Cancer 1Granulosa Cell Ovarian Cancer 1Fallopian Tube Neoplasms 1Erectile Dysfunction 1Epilepsy 1Endometrial Stromal Tumors 1ER+ Breast Cancer 1Carcinoma, Non-Small-Cell Lung 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasm Female 1

Interventions

Tadalafil 2udenafil 1mirabegron 1bicalutamide 1alpha-Tocopherol 1Vitamin E 1Tamoxifen 1Sildenafil Citrate 1Pentoxifylline 1Long-Term Synaptic Depression 1GPI 1485 1Erythropoietin 1Dutasteride 1Atorvastatin 1Arginine 1ArginMax 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Erectile Dysfunction × Anastrozole × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡